A report in Frontiers in Psychiatry describes two adolescents with persistent PANS/PANDAS who received home-based 1070-nm photobiomodulation and swLORETA neurofeedback alongside their care. Both showed improvements during the observation period, including reduced symptom burden and functional gains.
Why this is worth following The report brings attention to the practical question of how light-based interventions and neurofeedback might be studied together. Its clinical, cognitive and QEEG observations could help shape questions for prospective controlled research.
What the evidence supports This was a retrospective case series involving two people. Concurrent interventions and differing assessment schedules prevent conclusions about efficacy or which treatment contributed to the changes. These observations provide ideas to investigate, rather than an established treatment recommendation.
Source and disclosure Published September 3, 2026, by Brooke Hill in Frontiers in Psychiatry. The author disclosed a contracted role with Neuronic. The manufacturer loaned devices and covered limited QEEG-related costs.
Prepared with AI assistance and checked against the original publication on September 9, 2026.